Included with registration, selection made during registration process (non-cme events).


Tuesday, February 25 12:30 – 2:00pm (non-CME)
I1. Relevant Pathways, Novel Diagnostic and Therapeutic Approaches in Acute Organ Dysfunction
sponsored by Sphingotec

Wednesday, February 26 12:30 – 2:00pm (non-CME)
I2. Pathogen Reduction with a Novel Hemoperfusion Device: Seraph 100 (now CE marked)
sponsored by ExThera Medical

Development and History of Hemoperfusion Pathogen Reduction Device
Keith McCrea, CSO (ExThera Medical)

Clinical Need and Utilization
Professor Lakhmir Chawla MD (Veterans Affairs Medical Center, San Diego, CA)

Questions and Answers

Thursday, February 27, 6:45-8:00am (non-CME)

I3. Hemoadsorption as Extracorporeal Organ Support (ECOS) to Regain Control in Critically Ill Patients – An Update
sponsored by CytoSorbents
Chairs: J Kellum/Pittsburgh/USA and P Honoré/Brussels/Belgium

J Kellum/Pittsburgh/USA
Scientific background and safety data

C Ince /Rotterdam/The Netherlands
Influence on microcirculation, endothelial function and outcome in septic shock patients

J Stange /Rostock/Germany
Detoxification and control of inflammation as key elements in liver support therapy


I4. The Hepatocyte Growth Factor/c-Met pathway and its Role in AKI
sponsored by Angion

1. Introduce the HGF/c-Met pathway, including its history and the emerging science regarding its role in tissue repair

2. Educate on the functions and the therapeutic potential of HGF/c-Met pathway in AKI

Prakash Narayan, PhD,
VP Preclinical Research, Angion